Crimson staff writer
Anjeli R. Macaranas
Crimson staff writer Anjeli R. Macaranas can be reached at firstname.lastname@example.org.
Harvard Title IX Coordinator Nicole M. Merhill apologized for a statement she made last week, writing that it “has contributed to further concerns around trust.”
Researchers at Harvard’s T. H. Chan School of Public Health found earlier this month that Moderna’s coronavirus vaccine is slightly more effective than Pfizer’s at preventing negative Covid-19 outcomes.
Brigham and Women’s Hospital will begin treating patients this week in the first human trial for a nasal vaccine to prevent and slow Alzheimer’s disease.
Harvard Medical School received a $150,000 donation on Nov. 19 to support the current development of an office for community-centered medical education.
Harvard’s T.H. Chan School of Public Health announced a new academic and research collaboration with Tsinghua University’s Vanke School of Public Health in Beijing in a press release on Wednesday.
Dental School faculty worked "day and night" to ensure students stayed afloat with limited clinical instruction.
Faculty at Harvard Medical School developed an online, evidence-based video series to provide clinical guidelines for health care providers around the world and combat misinformation surrounding the Covid-19 pandemic.
Harvard epidemiologist Michael J. Mina is leaving academia for a leadership position at biotech software company eMed.
Mass General Brigham will invest $50 million in a new initiative focused on mental health, chronic disease management, and nutrition security, the hospital network announced last week.
Researchers at Harvard Medical School and Oxford University developed a new artificial intelligence model that can determine whether a gene variant is benign or disease-causing.